Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Substance Comparison
DMT and Ibogain are both classified as Psychedelika. DMT is commonly associated with a moderate risk profile compared to Ibogain.
Both substances belong to the Psychedelika class, making this a common comparison for understanding differences within the same pharmacological family.
| DMT | Ibogain | |
|---|---|---|
| Class | Psychedelika | Psychedelika |
| Risk Level | moderate | high |
| Mechanisms | 5-HT2A-Agonist, Sigma-1-Agonist | κ-Opioid-Agonist, NMDA-Antagonist, SERT-Inhibitor, σ-Rezeptor-Agonist |
| Receptors | 5-HT2A, 5-HT1A, Sigma-1 | κ-Opioid, NMDA, SERT, σ-1 |
| Effects | Sofortiger Wirkungseintritt: nach Sekunden vollständige Loslösung von der Umgebung, Breakthrough-Erfahrung: vollständig andere Dimensionen oder Realitäten bei hoher Dosis, Begegnungen mit geometrischen Strukturen, Fraktalen und „Entitäten", Extrem intensive visuelle Halluzinationen, leuchtende Farben und Muster, Vollständige Ich-Auflösung und Raum-Zeit-Kollaps |
DMT wirkt hauptsächlich als Agonist an Serotoninrezeptoren, insbesondere dem 5-HT2A-Rezeptor, was zu veränderten Bewusstseinszuständen und Halluzinationen führt.
Safer-use data available on substance page
No harm reduction data available
Evidence: unknown · Sources: 2
Evidence: not assessed · Sources: 2
| — |
| Evidence | unknown | — |